ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1111

Lupus Teledematology: A Pilot Project to Evaluate the Plausibility of a Rapid Access Dermatology Service for Lupus Patients

Richard Antbring1, Malvina Cunningham 2, Richard Bull 2, Angela Pakozdi 1, Ravindra Rajakariar 1, Myles Lewis 1, Andrea Cove-Smith 1 and Debasish Pyne 3, 1Barts Health Lupus Centre, London, United Kingdom, 2Barts Health NHS Trust, London, United Kingdom, 3Barts Lupus Centre, London, United Kingdom

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: cutaneous lupus, Lupus, quality improvement and access to care

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: Health Services Research Poster II – ACR/ARP

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Clinicians have been increasingly using social media sites professionally. Platforms such as WhatsApp ® could be a potentially effective tool in teledermatology for rapid diagnosis and/or triage.

Cutaneous disease is a  common manifestation of lupus but patients may also develop rashes not directly attributable to the disease and hence the importance of accurate diagnosis and management. In this study we introduced and service evaluated a WhatsApp® lupus telederm platform for diagnosis and management of cutaneous lesions in lupus patients attending clinic at an inner city Lupus Centre.

Methods: A WhatsApp ® group was created comprising all clinicians involved in the running of lupus clinics within the centre and included 2 senior dermatologists. Lupus patients who presented with skin lesions which posed diagnostic or management uncertainty were consented for lesion photography. Images were uploaded to WhatsApp ® along with relevant but brief clinical history. Patient confidentiality was protected by avoiding upload of any patient identifiable data. Dermatologist responses were collated and effectiveness of the service for patients was analysed.

Results: 1-year retrospective data from WhatsApp ® was evaluated. Images from 27 lupus patients had been uploaded for advice. Dermatologist advice could be categorised as either 1. Diagnosis and treatment advice (18 patients) (example – image1) or 2. Advice to refer to emergency dermatology clinic for further clinical evaluation (example – image 2) (9 patients). Patients in category 1 received a diagnosis and treatment institution within 48 hours. Those in category 2 were seen in dermatology clinic within 11 days where 7 underwent skin biopsy with subsequent diagnosis. The average time of a dermatologist to respond to queries was 1.1 days.

Conclusion: Our pilot project demonstrates that WhatsApp ® is an effective teledermatology platform for lupus patients with skin lesions allowing prompt evaluation and management.

Image 1

Image 2


Disclosure: R. Antbring, None; M. Cunningham, None; R. Bull, None; A. Pakozdi, None; R. Rajakariar, None; M. Lewis, None; A. Cove-Smith, None; D. Pyne, None.

To cite this abstract in AMA style:

Antbring R, Cunningham M, Bull R, Pakozdi A, Rajakariar R, Lewis M, Cove-Smith A, Pyne D. Lupus Teledematology: A Pilot Project to Evaluate the Plausibility of a Rapid Access Dermatology Service for Lupus Patients [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/lupus-teledematology-a-pilot-project-to-evaluate-the-plausibility-of-a-rapid-access-dermatology-service-for-lupus-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lupus-teledematology-a-pilot-project-to-evaluate-the-plausibility-of-a-rapid-access-dermatology-service-for-lupus-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology